kras mutation and glutathion glynac Oncogenic Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell KRAS | OriGene Technologies Inc.
KRAS OriGene Technologies Inc. Metabonomics study of the effects of single copy mutant KRAS in the presence or absence of WT allele using human HCT116 isogenic cell lines Metabolomics Springer Nature Link Oncometabolites in pancreatic cancer: Strategies and its implications PMC Targeting KRAS: from metabolic regulation to cancer treatment Molecular Cancer Springer Nature Link KRAS Targeted Therapy Doubles as Component of Immunotherapy NCI
Pay in 4 interest-free payments of $6.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




